Weiss Eric Stanton

Director Weiss buys 7,000 CORZ shares at $14.53; stock now $15.46 but down 32.5% from 52-week high amid -37.5% revenue decline.

Weiss Eric Stanton, a director at Core Scientific, purchased 7,000 shares at $14.53 on 2026-03-09, increasing his holdings to 252,262 shares. This buy occurs against a backdrop of significant company stress: revenue declined 37.5% year-over-year, the company reported a net loss of $146,660,000 in its latest quarter, and the stock has fallen 32.5% from its 52-week high of $22.90. At his same ticker (CORZ), Weiss's prior 4 buys showed mixed near-term outcomes (30-day range: -20.6% to +30.4%) but a strong 90-day timing pattern, with 3 of 4 prior purchases ultimately followed by gains. His cross-ticker track record shows a 75.00% 90-day win rate with an average 90-day return of +85.4%, though recent 30-day performance has been weak (average -1.4%). The purchase represents a 2.9% net increase to his CORZ position in a stock trading near the bottom of its annual range, but the company's deteriorating fundamentals—unprofitability and steep revenue contraction—create substantial execution risk regardless of historical insider timing accuracy.

CORZ Director Weiss buys 5,000 shares at $21.50; stock down 10.1% from 52-week high, but +20.4% in 30 days. Prior buys at CORZ all well-timed at 90-day mark.

Director Eric Stanton Weiss purchased 5,000 shares at $21.50, near the 52-week high of $22.90, during a strong 30-day run (+20.4%) and exceptional 90-day rally (+42.9%). Weiss's track record at CORZ is notable: his 3 prior purchases were all well-timed at the 90-day mark (posting +48.5%, +84.5%, and +225.5% respective 90-day returns), suggesting disciplined entry points or favorable timing luck. His cross-ticker record shows 100% win rate on buys with a 90-day average return of +119.5%. However, Core Scientific remains unprofitable (full-year net income: $-146.7M, latest quarter net income: $-146.7M) with minimal revenue growth (+1.6% annual), raising questions about valuation sustainability. The current price of $20.59 is already -10.1% below the transaction, indicating the near-term rally may be reversing.

Director Weiss buys 6,000 CORZ shares at $8.46; stock down -57.3% from 52-week high, yet insider's 2 prior CORZ buys yielded +30.4% and +225.5% at 90 days.

Director Eric Stanton Weiss purchased 6,000 shares at $8.46 on 2025-03-06, a discretionary open-market buy that increased his holdings from 215.7K to 221.7K shares. The stock is currently trading at $7.78, down -57.3% from its 52-week high of $18.23 and -38.8% over the preceding 30 days, suggesting a period of significant momentum loss. However, Weiss's prior transaction history at this ticker provides important context: his previous buys on 2024-09-09 and 2024-03-15 delivered 90-day returns of +30.4% and +225.5% respectively, and both trades proved well-timed by the 90-day mark. The current acquisition occurs against a fundamentals backdrop of company-wide unprofitability ($-455.3M net income in the latest full fiscal year) and minimal revenue growth at +1.6% annually, yet the insider's demonstrated pattern of well-timed entry points at this security warrants investor attention as a potential contra-sentiment signal during a period of sharp drawdown.

Director Eric Stanton Weiss purchases 5,000 shares of CORZ at $9.21; stock now at $10.01, up 3.2% in 30 days

Director Weiss Eric Stanton acquired 5,000 shares ($46,050.00 total) on 2024-09-09 at $9.21, expanding his position by 2.6% to 195,239 shares. The purchase occurred 8.2% below the current $10.01 price and within the 52-week range of $2.67–$11.70. His prior open-market buy at this ticker (2024-03-15) delivered a 90-day return of +225.5%, and this transaction falls within his 100% 90-day win rate across his trading history. However, the company reported an annual net loss of $-804.9M against $141.1M quarterly revenue and faces -21.5% annual revenue decline, indicating material operational headwinds despite the insider's continued accumulation and the stock's recent short-term gains.